PMF-1 Inhibitors belong to a distinct chemical class characterized by their ability to modulate the activity of PMF-1, a pivotal protein involved in cellular processes. PMF-1, short for Proliferation-Associated Nuclear Element 1, is a transcription factor that plays a critical role in regulating the expression of genes associated with cell proliferation and survival. The inhibitors designed to target PMF-1 operate at the molecular level, interacting specifically with the active sites of the protein to impede its function. These compounds typically exhibit a high degree of selectivity, honing in on the unique structural features of PMF-1 to disrupt its ability to bind to DNA and initiate transcriptional events.
PMF-1 Inhibitor class is notable, reflecting the intricate nature of the interactions between the inhibitors and the target protein. Researchers have employed various synthetic strategies to design molecules with optimal binding affinities and pharmacokinetic profiles. These inhibitors often comprise distinctive chemical motifs that facilitate their interaction with PMF-1, disrupting the downstream signaling cascades associated with uncontrolled cell proliferation. The elucidation of the three-dimensional structure of PMF-1 has significantly contributed to the rational design of these inhibitors, allowing for the development of more potent and selective compounds.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can affect AKT signaling, potentially altering PMF1-related processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor with a similar potential impact on AKT pathway as LY294002. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor that could indirectly affect PMF1 function through the MAPK/ERK pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that may influence cellular processes involving PMF1 through stress response pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which could modify PMF1 function by altering the JNK signaling pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that could impact protein synthesis and other processes related to PMF1. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
An Src family kinase inhibitor, potentially affecting signaling pathways involving PMF1. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that could indirectly affect PMF1 levels by altering protein degradation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Another proteasome inhibitor with potential influence on protein turnover, affecting PMF1-related pathways. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A tyrosine kinase inhibitor that may impact signaling pathways in which PMF1 is involved. | ||||||